Draghia-Akli Ruxandra bought NVAX
March 2, 2026 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 93,000 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
93,000
Price
$0.00
Total value
N/A
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 5, 2026
Shares owned after101,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third (1/3) of the RSUs subject to this grant under Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date.